A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study)
Top Cited Papers
Open Access
- 21 January 2011
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 9 (4), 700-710
- https://doi.org/10.1111/j.1538-7836.2011.04214.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or BCochrane Database of Systematic Reviews, 2011
- Haemophilic arthropathy: the importance of the earliest haemarthroses and consequences for treatmentHaemophilia, 2008
- Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe HemophiliaNew England Journal of Medicine, 2007
- Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIVBlood, 2007
- Current co‐ordinated activities of the PEDNET (European Paediatric Network for Haemophilia Management)Haemophilia, 2006
- Consensus perspectives on prophylactic therapy for haemophilia: summary statementHaemophilia, 2003
- Quality‐of‐life differences between prophylactic and on‐demand factor replacement therapy in European haemophilia patientsHaemophilia, 2002
- Primary prophylaxis in severe haemophilia should be started at an early age but can be individualizedBritish Journal of Haematology, 1999
- A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacsJournal of Internal Medicine, 1994
- Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and BJournal of Internal Medicine, 1992